A Phase I, Open, Randomized, Single-Dose, Two-Treatment (Fed Versus Fasting), Two-Period Cross-Over Single-Centre Study to Evaluate the Effect of Food on the Pharmacokinetics of AZD0328 Following Oral Administration (Capsule) in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2010
At a glance
- Drugs AZD 0328 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 28 Oct 2008 Actual patient number (14) added as reported by ClinicalTrials.gov.
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.